Floatz logo

Prag-1

Lymphopenia

Second Affiliated Hospital of Soochow UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Lymphopenia cohort.

Asset / SponsorPhaseRating
Talfirastide
Tarix Pharmaceuticals
Phase 2CCC
Ramifentanyl
Guizhi Du
UnknownD
Sevoflurane
Guizhi Du
UnknownD
Propofol
Guizhi Du
UnknownD

Same molecule, other indications

Prag-1 is also rated in:

cancerActive
CCC
Indicative · Phase 2
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →